PALVELLA THERAPEUTICS, INC. Balance Sheet
PVLA / Health Care|12 years of annual SEC 10-K data (FY2013-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 12 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$88M
FY2024
Cash
$84M
Cash and equivalents
Total Debt
N/A
FY2024
Shareholder Equity
$63M
FY2024
PALVELLA THERAPEUTICS, INC. had $88M in total assets and $63M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $83.6M | $7.3M | $38.6M | $117.8M | $70.4M | $62.3M | $74.9M | $29.4M | $29.4M | $29.4M | $18.5M | $3.7M |
| Accounts Receivable | $358.0K | $0 | $5.8M | $3.3M | $1.7M | $6.8M | $2.7M | $15.5M | $57.0K | $0 | $0 | $481.8K |
| Current Assets | $88.2M | $7.5M | $73.4M | $127.6M | $75.7M | $115.0M | $135.4M | $89.8M | $32.7M | $31.7M | $19.8M | $4.8M |
| PP&E (Net) | - | $0 | $17.0M | $19.1M | $22.0M | $19.5M | $5.0M | $4.0M | $2.3M | $2.2M | $2.1M | $2.4M |
| Total Assets | $88.2M | $7.5M | $95.5M | $153.6M | $105.0M | $141.1M | $141.3M | $103.9M | $35.1M | $34.0M | $21.9M | $7.3M |
| Current Liabilities | $12.0M | $2.4M | $36.6M | $50.6M | $22.1M | $27.0M | $48.1M | $45.8M | $8.4M | $2.8M | $3.5M | $1.8M |
| Shareholders' Equity | $62.6M | -$74.5M | -$93.8M | $31.0M | $51.4M | $51.4M | $11.5M | $25.2M | $25.2M | $31.1M | $18.0M | $585.0K |